| CASE REPORT |
|
| Year : 2019 | Volume
: 11
| Issue : 6 | Page : 241-243 |
|
|
Therapy-recalcitrant folliculitis decalvans controlled successfully with adalimumab
Meshal M Alhameedy1, Adel M Alsantali2
1 Department of Dermatology, Faculty of Medicine, Al Rass General Hospital, Ministry of Health, Ar Rass, Saudi Arabia
2 Department of Dermatology, Head of Hair Disorder Unit, King Fahed Armed Forced Hospital, Jeddah, Saudi Arabia
Correspondence Address:
Dr. Adel M Alsantali
Department of Dermatology, Head of Hair Disorder Unit, King Fahed Armed Forced Hospital, Jeddah
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijt.ijt_92_19
|
|
|
Folliculitis decalvans (FD) is a rare idiopathic primary cicatricial alopecia which leads to permanent destruction of hair follicular stem cell.Staphylococcus aureus as well as autoimmunity has been implicated in the pathogenesis. Treatment options include topical antiseptics, topical and systemic corticosteroids, systemic antibiotics, isotretinoin, dapsone, hydroxychloroquine, and immunomodulators. We present the therapy-recalcitrant case of FD which is controlled successfully by subcutaneous injections of Adalimumab (Humira®) with no serious adverse events throughout the treatment.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
